A First-in-Class Approach to Treating a Rare and Chronic Liver Disease

RARECast - Ein Podcast von RARECast - Donnerstags

Podimo 45 Tage kostenlos testen

Ein Universum voller exklusiver Podcasts und Hörbücher. Klicken Sie hier um loszulegen!

Werbung

Kategorien:

Wirtschaft

Sujal Shah, president and CEO of CymaBay Therapeutics, discusses the rare and chronic livers disease primary biliary cholangitis, Seladelpar, and why this first-in-class therapy has promise for addressing a condition with high unmet needs.

Visit the podcast's native language site